Positive experience of the usage of Rituximab in management of refractory myasthenia gravis in Russia

Cover Page

Cite item

Full Text

About the authors

N. I. Shcherbakova

Federal State Budgetary Research Institution “Research Center for Neurology”; 80 Volokolamskoe Shosse, Moscow, 125367, Russia

Author for correspondence.
Email: shnata@inbox.ru
Russian Federation

N. A. Suponeva

Federal State Budgetary Research Institution “Research Center for Neurology”; 80 Volokolamskoe Shosse, Moscow, 125367, Russia

Email: fake@neicon.ru
Russian Federation

V. V. Shvedkov

Federal State Budgetary Research Institution “Research Center for Neurology”; 80 Volokolamskoe Shosse, Moscow, 125367, Russia

Email: fake@neicon.ru
Russian Federation

A. A. Shabalina

Federal State Budgetary Research Institution “Research Center for Neurology”; 80 Volokolamskoe Shosse, Moscow, 125367, Russia

Email: fake@neicon.ru
Russian Federation

M. V. Kostyreva

Federal State Budgetary Research Institution “Research Center for Neurology”; 80 Volokolamskoe Shosse, Moscow, 125367, Russia

Email: fake@neicon.ru
Russian Federation

V. A. Rudnichenko

Federal State Budgetary Research Institution “Research Center for Neurology”; 80 Volokolamskoe Shosse, Moscow, 125367, Russia

Email: fake@neicon.ru
Russian Federation

O. I. Galkina

Federal State Budgetary Research Institution “Research Center for Neurology”; 80 Volokolamskoe Shosse, Moscow, 125367, Russia

Email: fake@neicon.ru
Russian Federation

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2015 Shcherbakova N.I., Suponeva N.A., Shvedkov V.V., Shabalina A.A., Kostyreva M.V., Rudnichenko V.A., Galkina O.I.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ЭЛ № ФС 77 - 85909 от  25.08.2023.